Fructooligosaccharide and Calcium Absorption in Adolescent Girls
NCT ID: NCT01005927
Last Updated: 2018-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
26 participants
INTERVENTIONAL
2009-01-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Calcium and Bone Mass in Young Females
NCT00000402
Bone Development in Adolescent Girls: Effects of Calcium and Exercise
NCT00063011
Encouraging Calcium Absorption and Bone Formation During Early Puberty
NCT00022867
Calcium Metabolism in Asian Adolescents
NCT00591708
Study of the Effect of a Calcium-rich Diet on Bone Health in Girls
NCT01058109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Fructooligosaccharide
0 g fructooligosaccharide added to calcium-containing beverage
Fructooligosaccharide
Zero or 3 g of a fructooligosaccharide will be administered in a beverage containing 300 mg total calcium as well as 15 mg 44Ca (calcium carbonate). Participants will be given one of the above beverages in addition to intravenously receiving 5 mg 43Ca (calcium chloride)in 10 ml saline.
3 g Fructooligosaccharide
3 g fructooligosaccharide added to calcium-containing beverage
Fructooligosaccharide
Zero or 3 g of a fructooligosaccharide will be administered in a beverage containing 300 mg total calcium as well as 15 mg 44Ca (calcium carbonate). Participants will be given one of the above beverages in addition to intravenously receiving 5 mg 43Ca (calcium chloride)in 10 ml saline.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fructooligosaccharide
Zero or 3 g of a fructooligosaccharide will be administered in a beverage containing 300 mg total calcium as well as 15 mg 44Ca (calcium carbonate). Participants will be given one of the above beverages in addition to intravenously receiving 5 mg 43Ca (calcium chloride)in 10 ml saline.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Calcium intake of 900-1300 mg/d
* Generally healthy
Exclusion Criteria
* BMI \> 90th percentile for age
* Takes medication that influences calcium metabolism
* Any disorder of calcium or bone homeostasis (hypercalcemia, Paget's Disease)
* Smoking, illegal drug consumption
* Any gastrointestinal disease (Crohn's Disease, Celiac Disease, Inflammatory Bowel Disease)
10 Years
12 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
GTC Nutrition
INDUSTRY
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Berdine Martin
Research Scientist, Nutrition Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Connie M Weaver, PhD
Role: PRINCIPAL_INVESTIGATOR
Purdue University
Berdine R Martin, PhD
Role: STUDY_DIRECTOR
Purdue University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue University
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GTC Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.